Using electronic monitoring to improve HIV medication adherence
Official title: Feasibility, acceptability, and pilot trial of a real-time electronic adherence monitoring intervention for antiretroviral therapy
Funded at University of Illinois at Chicago · NIH-10759928 · Data updated 2026-11-12
This study is testing a new way to help African American men who have sex with men remember to take their HIV medication on time by using a special system that sends reminders and includes support from friends or case managers to keep them motivated.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project start | August 1, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $710,727 |
| NIH project number | 1R34MH132432-01A1 |
| Project ID | NIH-10759928 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are African American men who have sex with men and are living with HIV.
✕Less likely to help
Patients who are not living with HIV or those who are already consistently adhering to their ART may not benefit from this research.
What this research studies
This research investigates a new method to help African American men who have sex with men (AAMSM) adhere to their antiretroviral therapy (ART) for HIV. It employs a real-time electronic adherence monitoring system that alerts users when they miss doses and involves social support to encourage adherence. The approach is designed to motivate patients and improve their medication-taking behaviors, ultimately aiming to suppress the viral load of HIV. The study will also explore how social support persons and case managers perceive and respond to notifications about missed doses.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence among patients with HIV, leading to better health outcomes and reduced transmission rates.
How similar studies have gone: Previous research has shown that electronic adherence monitoring can improve medication adherence, suggesting that this approach may be effective.
Where this research is happening
-
University of Illinois at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Dworkin, Mark S — University of Illinois at Chicago
- Study coordinator: Dworkin, Mark S
Related research
Other NIH-funded projects on the same topics.
-
MSC Secretome Eye Drops to Speed Healing of Corneal Wounds
A new eye drop made from stem cell–secreted factors is being tested to help adults with non-healing corneal wounds recover vision faster.
-
UIC Center for Healthy Work
A national program led by UIC aims to improve the health and well-being of workers through collaborative research and practical solutions.
-
Coordinated Oral Health Promotion for Chicago Kids
A long-running study in Chicago is following children and their caregivers to find ways to reduce tooth decay and improve daily life for families.
-
Targeting p38 MAPK to slow ALS-related axonal damage
Aims to block a specific brain-wide signaling pathway (p38 MAPK) to reduce nerve damage in people with various genetic forms of ALS.
-
Precision nanomedicine to calm inflammation and protect bone in gum disease
A new, targeted nanomedicine approach aims to reduce gum inflammation and prevent bone loss in adults with periodontal disease.
-
Role of DPP in Dental Pulp Stem Cells and their Regenerative Potential
A project explores how a natural tooth protein helps dental pulp stem cells repair and regenerate the tooth’s inner tissue.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.